November 2025 Newsletter – Our most versatile solution 🤝 Your latest product formulation
Breaking news - One ingredient, many solutions! Our new VAS (versatile application solution) technology hit the market November 6th.
The use of lycopene as a complementary medicine for Type II diabetes mellitus (T2DM) is limited and controversial. This study evaluated the effect of lycopene intake on the changes of glycaemic status and antioxidant capacity among the T2DM patients.
Breaking news - One ingredient, many solutions! Our new VAS (versatile application solution) technology hit the market November 6th.
BRANCHBURG, N.J., Oct. 29, 2025 /PRNewswire/ — Lycored, the global leader in naturally derived carotenoids for the food, beverage and dietary supplement market, is expanding its ingredient capabilities with the...
BEIJING and TEL AVIV, Israel, Oct. 22, 2025 /PRNewswire/ — ADAMA (SZSE: 000553), a global leader in crop protection, has announced the appointment of Dafna Cohen-Asher as Chief Executive Officer of Lycored,...
Interested in speaking directly with a member of our team?
Click below to get in touch.